Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-52,910
Closed -$1.84M 323
2020
Q4
$1.84M Buy
+52,910
New +$1.49M 0.3% 150

Other funds holding ADNT

EAM Investors's ADNT Position: Q1 2021 in Review

EAM Investors sold out of Adient (ADNT) in Q1 2021, closing a stake of 52,910 shares — an estimated $1.84M sold.

EAM Investors first reported a position in ADNT in Q4 2020 and held it in 1 quarter. The position peaked at $1.84M in Q4 2020. 300 funds tracked by Wall St. Rank hold ADNT as of Q1 2021.

  • EAM Investors reported no remaining Adient position as of Q1 2021 after selling out during the quarter.
  • EAM Investors sold 52,910 Adient shares in Q1 2021, an estimated $1.84M.
  • EAM Investors first reported a position in Adient in Q4 2020 and held it in 1 quarter.
  • EAM Investors's Adient position peaked at $1.84M in Q4 2020.
  • 300 funds tracked by Wall St. Rank held Adient as of Q1 2021.

Based on EAM Investors's 13F filing for Q1 2021, filed 11 May 2021.